by American Association for Cancer Research Credit: Unsplash/CC0 Public Domain Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10–13, 2024. The results of this...
Tag: <span>DCIS</span>
Post
Sentinel lymph node biopsy has no benefits for stage zero breast cancer
YALE UNIVERSITY New Haven, Conn. — Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has found. The study, believed to be the first to examine the long-term impact of sentinel lymph node biopsies on thousands of older women, found...